• English
  • Chinese
  • Home
  • Company
    •  
    • Company Profile
    • Corporate Culture
    • CEO Message
    • News & Events
    • Management Team
    • Our Facilities
    • Supporting Equipment
    • Intellectual Property Rights
  • Services & Solutions
    •  
    • PHARMACEUTICAL
      •  
      • Discovery Services:
      • Synthetic & Medicinal Chemistry
      • Analytical Chemistry
      • Discovery Biology
      • Pharmacology
      • Safety Pharmacology
      • Drug Metabolism and Pharmacokinetics
      • Bioanalytical
      • Development Services:
      • Process Research & Development
      • Research & Commercial Manufacturing
      • Analytical Development
      • Pharmaceutical Development Services
    • BIOLOGICS
      •  
      • Development Services
      • Testing Services
      • Manufacturing Services
      • VIROLOGY EXPERTISE
    • COMBINATION PRODUCTS
      •  
      • Combination Product Testing
      • Combination Product Manufacturing
      • Key Technical Staff
    • MEDICAL DEVICES
      •  
      •  
      • Proof of Concept and
        Process/Product Development
      • Medical Device Testing Services
      • Services for Tissue Products
    • TOXICOLOGY
      •  
      •  
      •  
      • Study Components/Additional Features
      • Testing Services
      • Facilities (St. Paul & Suzhou)
  • Literature
    •  
    • Categorized PDF Documents
    • Catalog of Services for Devices & Combo Products
  • Careers
    •  
    • Our Culture
    • Opportunities
  • Investor Relations
    •  
    • Company Profile
    • Corporate Governance
    • Press Releases
    • SEC Filings
    • Stock Information
    • Events Calender
    • Presentations
    • E-mail Alerts
    • Investor FAQs
    • Information Request
    • Contact IR
  • Client Support
    •  
    • Login (Project Tracking)
    • Contact an Account Manager
    • Contact a Facility
    • Test Request/Sample Submission Forms (PDF Downloads)
    • Quality Information & Certificates - U.S. Sites
    • News for the Biologics Industry
    • News for the Pharmaceutical Industry
    • News for the Combo Product/Device Industries
  • Contact
    •  
    • Contact Form / Email
    • Facilities / Phone Numbers
    • Account Managers
    • Investor Relations
  • Company Profile
  • Corporate Culture
  • CEO Message
  • News & Events
  • Management Team
  • Our Facilities
  • Supporting Equipment
  • Intellectual Property Rights
  • Pharmaceutical
  • Biologics
  • Combination Product
  • Medical Devices
  • Toxicology

News & Events

2010

News Archives: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

12/11/2010
WuXi PharmaTech Presents 2010 Life Science and Chemistry Awards

11/11/2010
WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility 

10/10/2010
WuXi PharmaTech Congratulates the 2010 Nobel Laureates in Chemistry

10/07/2010
Professor Steven V. Ley Speaks at WuXi PharmaTech

09/03/2010
Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification 

05/13/2010
Professor Eric N. Jacobsen Speaks at WuXi AppTec  

08/11/2010
WuXi PharmaTech Appoints Edward Hu as Chief Financial Officer

05/12/2010
WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer 

03/02/2010
WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training 

02/23/2010
WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai 

02/22/2010
WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility

01/20/2010
WuXi PharmaTech (NYSE: WX) Welcomes Mr. Wu Bangguo in Its Preclinical Testing Facility 

< prev | more >

© 2012 WuXi AppTec, All Rights Reserved
Privacy Policy
  • email page
  • Print Page